Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary( )

Authorization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines for children has ushered in a new phase of the immunization campaign to address the pandemic but has been received with mixed responses from parents, children, and opinion leaders. Herein we consider perceptions a...

Descripción completa

Detalles Bibliográficos
Autores principales: Weitzman, Elissa R, Sherman, Amy C, Levy, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Precision Vaccines Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129203/
https://www.ncbi.nlm.nih.gov/pubmed/35579499
http://dx.doi.org/10.1093/cid/ciac343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129203/
https://www.ncbi.nlm.nih.gov/pubmed/35579499
http://dx.doi.org/10.1093/cid/ciac343

Ejemplares similares